ArticleMolecular therapy. Methods & clinical development2022

Dose-dependent effects of a brain-penetrating iduronate-2-sulfatase on neurobehavioral impairments in mucopolysaccharidosis II mice.

Hideto Morimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.